Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.720
-0.020 (-1.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lineage Cell Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 417 | 111 | 191 | 199 | 413 | 264 | |
| Market Cap Growth | 144.46% | -41.93% | -4.09% | -51.84% | 56.44% | 98.01% | |
| Enterprise Value | 379 | 79 | 151 | 134 | 349 | 228 | |
| Last Close Price | 1.72 | 0.50 | 1.09 | 1.17 | 2.45 | 1.76 | |
| PS Ratio | 36.71 | 11.66 | 21.32 | 13.53 | 95.13 | 144.57 | |
| PB Ratio | 17.97 | 1.44 | 3.08 | 2.77 | 4.54 | 2.78 | |
| P/TBV Ratio | - | 5.23 | 30.84 | 12.45 | 11.89 | 6.86 | |
| P/FCF Ratio | - | - | - | 307.85 | - | - | |
| P/OCF Ratio | - | - | - | 187.79 | - | - | |
| EV/Sales Ratio | 35.03 | 8.36 | 16.88 | 9.11 | 80.50 | 124.70 | |
| EV/FCF Ratio | - | - | - | 207.31 | - | - | |
| Debt / Equity Ratio | 0.13 | 0.03 | 0.05 | 0.05 | 0.03 | 0.04 | |
| Debt / FCF Ratio | - | - | - | 6.03 | - | - | |
| Asset Turnover | 0.12 | 0.09 | 0.08 | 0.10 | 0.03 | 0.02 | |
| Quick Ratio | 4.33 | 3.47 | 2.02 | 3.07 | 2.32 | 5.35 | |
| Current Ratio | 4.50 | 3.65 | 2.14 | 3.16 | 2.37 | 5.66 | |
| Return on Equity (ROE) | -157.75% | -26.73% | -32.07% | -32.37% | -46.52% | -20.05% | |
| Return on Assets (ROA) | -13.65% | -12.53% | -11.80% | -9.44% | -21.77% | -14.16% | |
| Return on Capital (ROIC) | -27.95% | -18.58% | -18.82% | -16.61% | -31.93% | -15.35% | |
| Return on Capital Employed (ROCE) | -25.30% | -21.60% | -25.50% | -21.50% | -38.60% | -26.40% | |
| Earnings Yield | -16.23% | -16.80% | -11.27% | -13.21% | -10.42% | -7.82% | |
| FCF Yield | -5.01% | -21.36% | -15.33% | 0.33% | -5.79% | -7.51% | |
| Buyback Yield / Dilution | -25.54% | -15.94% | -1.69% | -3.22% | -9.64% | -3.10% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.